Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Collagen, type XXV, alpha 1
Introduction
Collagen alpha-1(XXV) chain is a protein that in humans is encoded by the COL25A1 gene.[1][2]
COL25A1 is a brain-specific membrane-bound collagen. Proteolytic processing releases CLAC, a soluble form of COL25A1 containing the extracellular collagen domains that associates with senile plaques in Alzheimer disease (AD; MIM 104300) brains (Osada et al., 2005).[supplied by OMIM][2]
Interactions
Interactions
Collagen, type XXV, alpha 1 has been shown to interact with Amyloid precursor protein.[1]
References
References
- ↑ 1.0 1.1 Hashimoto T, Wakabayashi T, Watanabe A, Kowa H, Hosoda R, Nakamura A, Kanazawa I, Arai T, Takio K, Mann DM, Iwatsubo T (Apr 2002). “CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV”. EMBO J. 21 (7): 1524–34. doi:10.1093/emboj/21.7.1524. PMC 125364. PMID 11927537.
- ↑ 2.0 2.1 “Entrez Gene: COL25A1 collagen, type XXV, alpha 1”.
Further reading
Further reading
- Kakuyama H, Söderberg L, Horigome K, et al. (2006). “CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation”. Biochemistry. 44 (47): 15602–9. doi:10.1021/bi051263e. PMID 16300410.
- Söderberg L, Dahlqvist C, Kakuyama H, et al. (2005). “Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates”. FEBS J. 272 (9): 2231–6. doi:10.1111/j.1742-4658.2005.04647.x. PMID 15853808.
- Osada Y, Hashimoto T, Nishimura A, et al. (2005). “CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils”. J. Biol. Chem. 280 (9): 8596–605. doi:10.1074/jbc.M413340200. PMID 15615705.
- Söderberg L, Kakuyama H, Möller A, et al. (2005). “Characterization of the Alzheimer’s disease-associated CLAC protein and identification of an amyloid beta-peptide-binding site”. J. Biol. Chem. 280 (2): 1007–15. doi:10.1074/jbc.M403628200. PMID 15522881.
- Kowa H, Sakakura T, Matsuura Y, et al. (2004). “Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits”. Am. J. Pathol. 165 (1): 273–81. doi:10.1016/s0002-9440(10)63295-6. PMC 1618534. PMID 15215182.
- Söderberg L, Zhukareva V, Bogdanovic N, et al. (2004). “Molecular identification of AMY, an Alzheimer disease amyloid-associated protein”. J. Neuropathol. Exp. Neurol. 62 (11): 1108–17. PMID 14656069.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.